This study is testing a pamphlet called CQUPLE (chart & question prompt list) to help patients with low-risk differentiated thyroid cancer (DTC), papillary thyroid microcarcinoma, or papillary thyroid carcinoma make treatment decisions. Low-risk thyroid cancer grows slowly, and survival is similar across different treatment options. The study aims to see if this decision aid helps reduce decisional conflict (difficulty in making a choice) for patients. You might be able to join if you are 18 or older, speak English, and have low-risk thyroid cancer or a suspicious thyroid nodule. You cannot have had a prior surgeon consultation for this issue, high-risk features, a history of thyroid cancer or surgery, or be pregnant. The study plans to enroll 34 participants, but its current recruitment status is unclear.

Study design

This is an interventional study, meaning participants will receive a specific intervention (the decision aid). It plans to include 34 participants.

What's involved

You would receive a decision aid after your cancer diagnosis and before meeting with a surgeon. Your decisional conflict will be measured at three points: at the start, after receiving the decision aid (within 30 days), and after your surgeon appointment (within 45 days).

Compensation

Not stated in the trial record.

Follow-up

Your decisional conflict will be measured up to approximately 45 days after receiving the decision aid and attending your surgeon appointment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.